CN111944000A - 5-substituted-2, 4-dithio-2 ', 3' -O-di-tert-butyldisilyl nucleoside compound and synthetic method thereof - Google Patents

5-substituted-2, 4-dithio-2 ', 3' -O-di-tert-butyldisilyl nucleoside compound and synthetic method thereof Download PDF

Info

Publication number
CN111944000A
CN111944000A CN202010961405.7A CN202010961405A CN111944000A CN 111944000 A CN111944000 A CN 111944000A CN 202010961405 A CN202010961405 A CN 202010961405A CN 111944000 A CN111944000 A CN 111944000A
Authority
CN
China
Prior art keywords
compound
reaction
anhydrous
substituted
synthesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN202010961405.7A
Other languages
Chinese (zh)
Inventor
张晓辉
李若婕
李德鹏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dalian University
Original Assignee
Dalian University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalian University filed Critical Dalian University
Priority to CN202010961405.7A priority Critical patent/CN111944000A/en
Publication of CN111944000A publication Critical patent/CN111944000A/en
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

The invention belongs to the field of synthetic chemistry, and discloses a 5-substituted-2, 4-dithio-2 ', 3' -O-di-tert-butyldisilyl nucleoside compound and a synthetic method thereof. Under the protection of nitrogen, reacting a 5-substituted deoxynucleoside compound with tert-butyldimethylsilyl chloride (TBSCl), and performing post-treatment after the reaction to obtain a compound a; dissolving the compound a and 1,2, 4-triazole in an anhydrous acetonitrile solvent for reaction to obtain a light yellow solid b; finally, reacting the compound b with thioacetic acid in anhydrous acetonitrile to obtain a yellow solid compound c; finally compound c was stirred with Lawesson's Reagent in 80 ℃ dry toluene overnight to give final product d. Provides a synthesis method of 5-substituted-2, 4-dithio-2 ', 3' -O-di-tert-butyldisilyl nucleoside compound, which is simple, efficient, mild and simple in post-treatment. The synthesis method has the advantage of avoiding using H with high toxicity in the synthesis process2S gas and expensive chloro-sugar compounds with poor quality guarantee period, and the like.

Description

5-substituted-2, 4-dithio-2 ', 3' -O-di-tert-butyldisilyl nucleoside compound and synthetic method thereof
Technical Field
The invention belongs to the technical field of chemical synthesis, and relates to a 5-substituted-2, 4-dithio-2 ', 3' -O-di-tert-butyldimethylsilyl nucleoside compound and a synthesis method thereof.
Background
Natural nucleosides, which are glycosides of ribose or deoxyribose and a base (e.g., adenine, thymine, guanine, cytosine, or uracil), are important components of DNA and RNA and play irreplaceable roles in natural life activities. Since the isolation of 4-thiouracil nucleotides from E.coli by Lipsett M.N.the Journal of biological chemistry,1965,240(10), sulfur-containing bases and nucleosides have attracted considerable research interest.
Compared with natural nucleotide, the pyrimidine ring series nucleoside compound containing sulfhydryl group has anticancer activity and immunity enhancement effect (NIGMN SC, SAHARA GS, SHAMM HR. Indian Chem Soc, 1983, 60: 583-.
4-thio nucleoside analogues have been found to be very sensitive to ultraviolet radiation and to be potentially useful as anti-neoplastic agents, particularly in combination with near ultraviolet light (UVA) for the treatment of skin cancer (Pridgon SW, Heer R, Taylor GABr. J. cancer 2011,104,1869.). Thus, bradyflares and Karran et al (Massey M, Xu YZ, Karran p. curr. biol.2011,11,1142) propose a new photochemotherapeutic approach, i.e. ultraviolet light assisted 4-thiothymidine therapy. The therapy utilizes the characteristics that thiothymidine has a similar structure with natural thymidine and cancer cells can rapidly and self-replicate and grow in a human body, 4-thiothymidine analogues are incorporated into cancerated tissues, and DNA of the cancer cells is selectively damaged through interaction with UVA with a specific wavelength, so that the aims of selectively killing the cancer cells and reducing drug cytotoxicity are fulfilled.
S due to limited tissue penetration of UVA4TdR/UVA therapy is effective against malignancies in some solid organs close to the skin surface, such as the skin surface, urinary tract, digestive tract, upper respiratory tract, etc. For some malignancies in solid organs that are inaccessible to UVA, this therapy may not work well, such as lung, brain, liver, kidney.
Therefore, in order to solve the problem, based on 4-thiodeoxythymidine, new structural modification and substitution are carried out, so that the absorption wavelength of a thio compound is developed to a visible light region, and the development of the thio compound is matched with the development of optical fibers in clinic, which means that the therapy can be applied to the treatment of the deep-source tumor in future.
Marvin polar proposes that the maximum absorption wavelength of 2, 4-dithiothymine is at 363nm (Pollum M, Jockusch S, Crespo-Hernandez CE.J Am Chem Soc.2014; 136(52):17930-3.), which provides a theoretical basis for realizing the development of the absorption wavelength of a thio compound to a visible light region. However, the synthesis method of the disulfide compound is only reported in documents, so that the disulfide compound has important significance for the development of the sulfur-containing nucleoside derivatives and the research on the synthesis method.
Disclosure of Invention
In order to overcome the defects of the prior art, the invention provides a 5-substituted-2, 4-dithio-2 ', 3' -O-di-tert-butyldisilyl nucleoside compound and a synthesis method thereof. The synthesis method is simple, efficient, mild and simple in post-treatment.
The above purpose of the invention is realized by the following technical scheme:
a 5-substituted-2, 4-dithio-2 ', 3' -O-di-tert-butyldisilyl nucleoside compound; having the general formula (d):
Figure BDA0002680682550000031
wherein X is CH3、H、F、Cl、Br、I。
The specific structural formula of the 5-substituted-2, 4-dithio-2 ', 3' -O-di-tert-butyldisilyl nucleoside compound is as follows:
Figure BDA0002680682550000032
wherein A is deoxythymidine, B is deoxyuridine, C is 5-fluorodeoxynucleoside, D is 5-chlorodeoxynucleoside, E is 5-bromodeoxynucleoside, and F is 5-iododeoxynucleoside. .
A 5-substituted-2, 4-dithio-2 ', 3' -O-di-tert-butyldisilyl nucleoside compound and a synthesis method thereof; taking deoxynucleoside as a raw material, taking a Lawson reagent as a vulcanizing agent, and carrying out chemical reaction in an anhydrous toluene solvent to finally obtain a compound shown as a general formula d;
Figure BDA0002680682550000041
wherein, X is H, CH3、F、Cl、Br、I。
Further, the synthesis method of the 5-substituted-2, 4-dithio-2 ', 3' -O-di-tert-butyldisilyl nucleoside compound comprises the following steps: under the protection of nitrogen, reacting a 5-substituted deoxynucleoside compound with tert-butyldimethylsilyl chloride (TBSCl), and performing post-treatment after the reaction to obtain a compound a; dissolving the compound a and 1,2, 4-triazole in an anhydrous acetonitrile solvent for reaction to obtain a light yellow solid b; finally, reacting the compound b with thioacetic acid in anhydrous acetonitrile to obtain a yellow solid compound c; finally compound c was stirred with Lawesson's Reagent in 80 ℃ dry toluene overnight to give final product d.
Further, the synthesis method of the 5-substituted-2, 4-dithio-2 ', 3' -O-di-tert-butyldisilyl nucleoside compound comprises the following steps:
s1, synthesis of a compound a: under the protection of nitrogen, 1 equivalent of 5-substituted deoxynucleoside compound and 3 equivalents of imidazole are dissolved in dichloromethane and stirred for 30 minutes in ice water bath (0 ℃); after 30 minutes, adding 2.5 equivalents of tert-butyldimethylsilyl chloride (TBSCl) into the reaction system, and stirring at room temperature for 1 hour; after TLC detection reaction is finished, quenching with water and extracting with dichloromethane; the organic phases were combined, washed with saturated NaCl and anhydrous NaSO4Drying, filtering, and evaporating the solvent under reduced pressure to obtain compound a as white solid, which is directly subjected to the next step S2 without purification;
s2, synthesis of a compound b: dissolving 14 equivalents of 1,2, 4-triazole in anhydrous acetonitrile, and slowly adding phosphorus oxychloride and triethylamine under stirring in an ice-water bath (0 ℃); after 1 hour of reaction, 1 equivalent of the white solid compound a prepared in S1 was added and stirred at room temperature overnight; after TLC detection reaction, the reaction solution is filtered, and the organic phase is diluted with dichloromethane and saturatedAnd NaHCO3Solution washing, saturated NaCl solution washing, anhydrous Na2SO4Drying, filtering, and evaporating the solvent under reduced pressure to obtain a compound b which is a light yellow solid and is directly subjected to the next step S3 without purification;
s3, synthesis of a compound c: dissolving 1 equivalent of the compound b in anhydrous acetonitrile, adding 14 equivalents of thioacetic acid, and stirring at room temperature overnight; after TLC detection reaction is finished, the reaction solution is diluted by dichloromethane and saturated NaHCO3Solution washing, saturated NaCl solution washing, anhydrous Na2SO4Drying, filtering, decompressing and distilling off the solvent to obtain yellow solid, and separating and purifying by a silica gel column to obtain a compound c;
s4, synthesis of a compound d: 1 equivalent of compound c was dissolved in anhydrous toluene, 2 equivalents of Lawesson's Reagent were added and stirred at 80 ℃ overnight. And (5) separating and purifying by a silica gel column to obtain a compound d as a yellow solid.
Further, the temperature of the compound c in the anhydrous toluene reaction in the step S4 was 80 ℃.
Compared with the prior art, the invention has the beneficial effects that:
the invention provides a synthesis method for preparing the 5-substituted-2, 4-dithio-2 ', 3' -O-di-tert-butyldisilyl nucleoside compound. In the synthesis from the compounds (b) to (d), the purpose of sulfurizing at the 4-position of a deoxynucleoside compound is achieved first by sulfurizing a deoxynucleoside with a triazole, followed by sulfurizing at the 2-position of a 4-thiodeoxynucleoside compound with a Lawson reagent, by changing the order of the sulfurization on the deoxynucleoside compound, and by using two sulfurizing reagents, thioacetic acid and Lawson reagent, respectively, the purpose of synthesizing a 5-substituted-2, 4-dithio-2 ', 3' -O-di-t-butyldimethylsilyl nucleoside compound is achieved. The synthesis method has the advantages of mild conditions, little environmental pollution, high yield, easy separation and purification and the like, and avoids the use of H which is flammable and explosive and has high toxicity in the synthesis process2S gas, avoiding passing through H2S gas is synthesized into 2-thiodeoxynucleoside and then synthesized into 2, 4-dithiodeoxynucleoside, and the complex means of low yield and configuration change avoids the use of expensive chloro-sugar compounds with poor quality guarantee period and the like.
Drawings
FIG. 1 is a nuclear magnetic characterization map of compound a1 of example 1 of the present invention.
FIG. 2 is a nuclear magnetic characterization map of compound b1 of example 1 of the present invention.
FIG. 3 is a nuclear magnetic characterization map of compound c1 of example 1 of the present invention.
FIG. 4 is a nuclear magnetic characterization map of compound d1 of example 1 of the present invention.
Detailed Description
The invention is described in more detail below with reference to specific examples, without limiting the scope of the invention. Unless otherwise specified, the experimental methods adopted by the invention are all conventional methods, and experimental equipment, materials, reagents and the like used in the experimental method can be obtained from commercial sources.
Example 1
2, 4-dithio-2 ', 3' -O-di-tert-butyldisilyl deoxythymidine with the structural formula of d1As shown in the drawings, the above-described,
Figure BDA0002680682550000061
s1. Compound a1The synthesis of (2): deoxythymidine (3g) and imidazole (2.52g) were dissolved in dichloromethane (20ml) under nitrogen and stirred for 30 minutes in an ice-water bath. After 30 minutes, t-butyldimethylsilyl chloride (TBSCl) (4.65g) was added to the reaction system, and the mixture was stirred at room temperature for 1 hour. After the TLC detection reaction, the reaction mixture was quenched with water and extracted with dichloromethane. The organic phases were combined, washed with saturated NaCl and anhydrous NaSO4Drying, filtering, and vacuum evaporating to remove solvent to obtain compound a1As a white solid, 5.8g, yield 99%, the next step S2 was carried out without purification.1H NMR(CDCl3,500MHz):8.11(s,1H),7.48(s,1H),6.34(t,J=6.7Hz,1H),4.42–4.36(m,1H),3.95–3.72(m,3H),2.27–2.19(m,1H),2.05–1.96(m,1H),1.92(s,3H),0.91(d,J=17.9Hz,18H),0.14–0.04(m,12H)。
S2. Compound b1The synthesis of (2): 1,2, 4-triazole (10.22g) was dissolved in anhydrous acetonitrile (1)20ml), phosphorus oxychloride (3.192ml) and triethylamine (24ml) were added slowly with stirring in an ice-water bath. After 1 hour of reaction, compound a1 white solid (5g) prepared in S1 above was charged and stirred at room temperature overnight. After TLC detection, the reaction solution was filtered, the organic phase was diluted with dichloromethane and saturated NaHCO3Solution washing, saturated NaCl solution washing, anhydrous Na2SO4Drying, filtering, and vacuum evaporating to remove solvent to obtain compound b1As a pale yellow solid, 5.16g, yield 99%, and was directly subjected to the next step S3 without purification.1H NMR(CDCl3,500MHz):9.28(s,1H),8.25(s,1H),8.11(s,1H),6.29(t,J=6.2Hz,1H),4.39(s,1H),4.06(s,1H),3.88(dd,J=83.3,11.5Hz,3H),2.67–2.54(m,1H),2.44(s,3H),2.08(dd,J=13.3,6.5Hz,1H),0.90(d,J=7.9Hz,18H),0.09(dd,J=17.8,6.5Hz,12H)。
S3. Compound c1The synthesis of (2): compound b1(5g) Was dissolved in anhydrous acetonitrile (191ml), and thioacetic acid (9.6ml) was added thereto, followed by stirring at room temperature overnight. After TLC detection reaction is finished, the reaction solution is diluted by dichloromethane and saturated NaHCO3Solution washing, saturated NaCl solution washing, anhydrous Na2SO4Drying, filtering, distilling under reduced pressure to remove solvent to obtain yellow solid, separating and purifying with silica gel column to obtain compound c13.74g, yield 80%.1H NMR(CDCl3,500MHz):9.39(s,1H),7.51(s,1H),6.21(t,J=6.7Hz,1H),4.34(s,1H),3.91(s,1H),3.86–3.65(m,2H),2.29–2.20(m,1H),2.04(s,3H),1.95(dt,J=13.2,6.8Hz,1H),0.85(d,J=15.1Hz,18H),0.04(d,J=15.7Hz,12H)。
S4, synthesis of a compound 4: compound c1(2g) Dissolved in anhydrous toluene (17ml), and Lawesson's Reagent (3.32g) was added thereto, followed by stirring at 80 ℃ overnight. Separating and purifying by silica gel column to obtain compound d1As a yellow solid, 1.13g, 55% yield.1H NMR(CDCl3,500MHz):10.62(s,1H),7.73(s,1H),6.74(t,J=6.3Hz,1H),4.38(s,1H),4.05–3.73(m,3H),2.56(dt,J=13.2,4.3Hz,1H),2.12(s,3H),1.97(dt,J=13.2,6.7Hz,1H),0.91(d,J=10.3Hz,18H),0.12(d,J=4.1Hz,6H),0.09(d,J=8.4Hz,6H).
Example 2
2, 4-dithio-2 ', 3' -O-di-tert-butyldisilyldioxouridine; the structural formula is shown as the general formula d2As shown in the drawings, the above-described,
Figure BDA0002680682550000081
s1. Compound a2The synthesis of (2): deoxyuridine (5g) and imidazole (4.49g) were dissolved in dichloromethane (34ml) under nitrogen protection and stirred for 30 minutes in an ice-water bath. After 30 minutes, tert-butyldimethylsilyl chloride (TBSCl) (8.3g) was added to the reaction system, and the mixture was stirred at room temperature for 1 hour. After the TLC detection reaction, the reaction mixture was quenched with water and extracted with dichloromethane. The organic phases were combined, washed with saturated NaCl and anhydrous NaSO4Drying, filtering, and vacuum evaporating to remove solvent to obtain compound a2As a white solid, 9.9g, yield 99%, the next step S2 was carried out without purification.1H NMR(CDCl3,500MHz):8.72(s,1H),7.95–7.87(m,1H),6.30(t,J=6.1Hz,1H),5.69(d,J=8.1Hz,1H),4.41(dd,J=6.0,3.6Hz,1H),3.83(dd,J=73.6,11.5Hz,3H),2.32(dt,J=10.8,5.0Hz,1H),2.07(dt,J=12.7,5.8Hz,1H),0.91(d,J=15.0Hz,18H),0.09(d,J=15.3Hz,12H)。
S2. Compound b2The synthesis of (2): 1,2, 4-triazole (6.7g) was dissolved in anhydrous acetonitrile, and phosphorus oxychloride (2.1ml) and triethylamine (15.8ml) were slowly added with stirring in an ice-water bath. After 1 hour of reaction, the compound a prepared in S1 described above was charged2White solid (3g), stirred at rt overnight. After TLC detection, the reaction solution was filtered, the organic phase was diluted with dichloromethane and saturated NaHCO3Solution washing, saturated NaCl solution washing, anhydrous Na2SO4Drying, filtering, and vacuum evaporating to remove solvent to obtain compound b2As a pale yellow solid, 3.3g, yield 99%, and was directly subjected to the next step S3 without purification.
S3. Compound c2The synthesis of (2): compound b2(3g) Dissolving in anhydrous acetonitrile, adding thioacetic acid (5.9ml, stirring overnight at room temperature, detecting by TLC, diluting the reaction solution with dichloromethane, and saturatingNaHCO3Solution washing, saturated NaCl solution washing, anhydrous Na2SO4Drying, filtering, distilling under reduced pressure to remove solvent to obtain yellow solid, separating and purifying with silica gel column to obtain compound c22.17g, yield 78%.1H NMR(CDCl3,500MHz):9.58(s,1H),7.81(s,1H),6.42–6.32(m,1H),6.23(q,J=6.0,4.3Hz,1H),3.96–3.71(m,3H),2.52(d,J=4.7Hz,1H),2.35(h,J=4.8Hz,1H),2.12–2.03(m,1H),0.90(d,J=15.6Hz,18H),0.09(d,J=13.9Hz,12H)。
S4. Compound d2The synthesis of (2): compound c2(2g) Dissolved in anhydrous toluene (17ml), and Lawesson's Reagent (3.4g) was added thereto, followed by stirring at 80 ℃ overnight. Separating and purifying by silica gel column to obtain compound d2As a yellow solid, 1.027g, 50% yield.
Example 3
5-F-2, 4-dithio-2 ', 3' -O-di-tert-butyldisilyldisiloxyuridine; the structural formula is shown as the general formula d3As shown in the drawings, the above-described,
Figure BDA0002680682550000101
s1. Compound a3The synthesis of (2): deoxythymidine (5g) and imidazole (4.15g) were dissolved in dichloromethane (34ml) under nitrogen and stirred for 30 minutes in an ice-water bath. After 30 minutes, t-butyldimethylsilyl chloride (TBSCl) (7.65g) was added to the reaction system, and the mixture was stirred at room temperature for 1 hour. After the TLC detection reaction, the reaction mixture was quenched with water and extracted with dichloromethane. The organic phases were combined, washed with saturated NaCl and anhydrous NaSO4Drying, filtering, and vacuum evaporating to remove solvent to obtain compound a3As a white solid, 9.54g, yield 99%, the next step S2 was carried out without purification.1H NMR(CDCl3,500MHz):8.62(s,1H),8.07(d,J=6.2Hz,1H),6.30(t,J=6.0Hz,1H),4.41(dt,J=6.2,3.1Hz,1H),3.94(d,J=12.5Hz,2H),3.77(d,J=11.1Hz,1H),2.32(ddd,J=13.2,6.1,3.5Hz,1H),2.06(p,J=6.3Hz,1H),0.91(d,J=19.1Hz,18H),0.11(dd,J=24.6,2.9Hz,12H)。
S2. Compound b3The synthesis of (2): 1,2, 4-triazole (6.44g) was dissolved in anhydrous acetonitrile (41.05ml), and phosphorus oxychloride (153.33ml) and triethylamine (101.19ml) were added slowly with stirring in an ice-water bath. After 1 hour of reaction, the compound a prepared in S1 described above was charged3White solid (3g), stirred at rt overnight. After TLC detection, the reaction solution was filtered, the organic phase was diluted with dichloromethane and saturated NaHCO3Solution washing, saturated NaCl solution washing, anhydrous Na2SO4Drying, filtering, and vacuum evaporating to remove solvent to obtain compound b3As a pale yellow solid, 3.28g, yield 99%, and was directly subjected to the next step S3 without purification.1H NMR(CDCl3,500MHz):9.26(s,1H),8.86(d,J=6.0Hz,1H),8.22(s,1H),6.23(d,J=5.3Hz,1H),4.41(d,J=4.8Hz,1H),4.15–3.97(m,3H),3.83(d,J=11.5Hz,1H),2.61(dq,J=13.2,6.3,5.2Hz,1H),2.23(dt,J=13.5,5.0Hz,1H),2.05(s,0H),0.94(s,9H),0.89(s,9H),0.15(d,J=9.9Hz,6H),0.08(s,6H)。
S3. Compound c3The synthesis of (2): compound b3(3g) Was dissolved in anhydrous acetonitrile (115ml), and thioacetic acid (5.7ml) was added thereto, followed by stirring at room temperature overnight. After TLC detection reaction is finished, the reaction solution is diluted by dichloromethane and saturated NaHCO3Solution washing, saturated NaCl solution washing, anhydrous Na2SO4Drying, filtering, distilling under reduced pressure to remove solvent to obtain yellow solid, separating and purifying with silica gel column to obtain compound c32.26g, yield 81%.1H NMR(CDCl3,500MHz):9.50(s,1H),8.05(d,J=3.9Hz,1H),6.23(d,J=5.4Hz,1H),4.42(s,1H),3.99–3.66(m,3H),2.39–2.24(m,1H),2.09(dt,J=12.9,5.7Hz,1H),0.91(d,J=18.8Hz,18H),0.17–-0.00(m,12H)。
S4. Compound d3The synthesis of (2): compound c3(2g) Dissolved in anhydrous toluene (16ml), and Lawesson's Reagent (3.23g) was added thereto, followed by stirring at 80 ℃ overnight. Separating and purifying by silica gel column to obtain compound d3As a yellow solid, 1.054g, 52% yield.1H NMR(CDCl3,500MHz):10.52(s,1H),8.23(d,J=3.7Hz,1H),6.61(t,J=5.3Hz,1H),4.40(t,J=5.3Hz,1H),4.06–3.78(m,3H),2.54(dt,J=13.1,6.1Hz,1H),2.15(dq,J=13.7,5.7,4.5Hz,1H),0.93(s,9H),0.89(s,9H),0.11(dd,J=23.3,5.7Hz,12H)。
The embodiments described above are merely preferred embodiments of the invention, rather than all possible embodiments of the invention. Any obvious modifications to the above would be obvious to those of ordinary skill in the art, but would not bring the invention so modified beyond the spirit and scope of the present invention.

Claims (4)

1. A5-substituted-2, 4-dithio-2 ', 3' -O-di-tert-butyldisilyl nucleoside compound characterized by having a structure of the general formula (d):
Figure FDA0002680682540000011
wherein X is CH3、H、F、Cl、Br、I。
2. The method for synthesizing a 5-substituted-2, 4-dithio-2 ', 3' -O-di-t-butyldimethylsilyl nucleoside compound according to claim 1, wherein the synthesizing step is: under the protection of nitrogen, reacting the 5-substituted deoxynucleoside compound with tert-butyldimethylsilyl chloride, and performing post-treatment after the reaction is finished to obtain a compound a; dissolving the compound a and 1,2, 4-triazole in an anhydrous acetonitrile solvent for reaction to obtain a light yellow solid b; finally, reacting the compound b with thioacetic acid in anhydrous acetonitrile to obtain a yellow solid compound c; finally, the compound c was stirred with lawson's reagent in anhydrous toluene at 80 ℃ overnight to give the final product d.
3. The method for synthesizing a 5-substituted-2, 4-dithio-2 ', 3' -O-di-t-butyldimethylsilyl nucleoside compound according to claim 2, wherein the synthesizing step is:
s1, synthesis of a compound a: under the protection of nitrogen, dissolving 5-substituted deoxynucleoside compound and imidazole in dichloromethane, stirring in ice-water bath, and adding tert-butyl dimethyl silicon chlorideAlkane, stirring for 1 hour at room temperature; after TLC detection reaction is finished, quenching with water and extracting with dichloromethane; the organic phases were combined, washed with saturated NaCl and anhydrous NaSO4Drying, filtering, and evaporating the solvent under reduced pressure to obtain compound a as white solid, which is directly subjected to the next step S2 without purification;
s2, synthesis of a compound b: dissolving 1,2, 4-triazole in anhydrous acetonitrile, and slowly adding phosphorus oxychloride and triethylamine under the stirring of ice-water bath; after the reaction, 1 equivalent of the white solid compound a prepared in S1 was added and stirred at room temperature overnight; after TLC detection, the reaction solution was filtered, the organic phase was diluted with dichloromethane and saturated NaHCO3Solution washing, saturated NaCl solution washing, anhydrous Na2SO4Drying, filtering, and evaporating the solvent under reduced pressure to obtain a compound b which is a light yellow solid and is directly subjected to the next step S3 without purification;
s3, synthesis of a compound c: dissolving the compound b in anhydrous acetonitrile, adding 14 equivalents of thioacetic acid, and stirring at room temperature overnight; after TLC detection reaction is finished, the reaction solution is diluted by dichloromethane and saturated NaHCO3Solution washing, saturated NaCl solution washing, anhydrous Na2SO4Drying, filtering, decompressing and distilling off the solvent to obtain yellow solid, and separating and purifying by a silica gel column to obtain a compound c;
s4, synthesis of a compound d: 1 equivalent of compound c was dissolved in anhydrous toluene, added with Lawson's reagent and stirred at 80 ℃ overnight. And (5) separating and purifying by a silica gel column to obtain a compound d as a yellow solid.
4. The method for synthesizing a 5-substituted-2, 4-dithio-2 ', 3' -O-di-tert-butyldimethylsilyl nucleoside compound according to claim 3, wherein the synthesizing step is specifically:
s1, synthesis of a compound a: under the protection of nitrogen, 1 equivalent of 5-substituted deoxynucleoside compound and 3 equivalents of imidazole are dissolved in dichloromethane and stirred for 30 minutes in ice-water bath; after 30 minutes, adding 2.5 equivalents of tert-butyldimethylsilyl chloride into the reaction system, and stirring for 1 hour at room temperature; after TLC detection reaction is finished, quenching with water and extracting with dichloromethane;the organic phases were combined, washed with saturated NaCl and anhydrous NaSO4Drying, filtering, and evaporating the solvent under reduced pressure to obtain compound a as white solid, which is directly subjected to the next step S2 without purification;
s2, synthesis of a compound b: dissolving 14 equivalents of 1,2, 4-triazole in anhydrous acetonitrile, and slowly adding phosphorus oxychloride and triethylamine under the stirring of ice-water bath; after 1 hour of reaction, 1 equivalent of the white solid compound a prepared in S1 was added and stirred at room temperature overnight; after TLC detection, the reaction solution was filtered, the organic phase was diluted with dichloromethane and saturated NaHCO3Solution washing, saturated NaCl solution washing, anhydrous Na2SO4Drying, filtering, and evaporating the solvent under reduced pressure to obtain a compound b which is a light yellow solid and is directly subjected to the next step S3 without purification;
s3, synthesis of a compound c: dissolving 1 equivalent of the compound b in anhydrous acetonitrile, adding 14 equivalents of thioacetic acid, and stirring at room temperature overnight; after TLC detection reaction is finished, the reaction solution is diluted by dichloromethane and saturated NaHCO3Solution washing, saturated NaCl solution washing, anhydrous Na2SO4Drying, filtering, decompressing and distilling off the solvent to obtain yellow solid, and separating and purifying by a silica gel column to obtain a compound c;
s4, synthesis of a compound d: 1 equivalent of compound c was dissolved in anhydrous toluene, 2 equivalents of lawson's reagent was added, and stirring was carried out overnight at 80 ℃. And (5) separating and purifying by a silica gel column to obtain a compound d as a yellow solid.
CN202010961405.7A 2020-09-14 2020-09-14 5-substituted-2, 4-dithio-2 ', 3' -O-di-tert-butyldisilyl nucleoside compound and synthetic method thereof Withdrawn CN111944000A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010961405.7A CN111944000A (en) 2020-09-14 2020-09-14 5-substituted-2, 4-dithio-2 ', 3' -O-di-tert-butyldisilyl nucleoside compound and synthetic method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010961405.7A CN111944000A (en) 2020-09-14 2020-09-14 5-substituted-2, 4-dithio-2 ', 3' -O-di-tert-butyldisilyl nucleoside compound and synthetic method thereof

Publications (1)

Publication Number Publication Date
CN111944000A true CN111944000A (en) 2020-11-17

Family

ID=73356514

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010961405.7A Withdrawn CN111944000A (en) 2020-09-14 2020-09-14 5-substituted-2, 4-dithio-2 ', 3' -O-di-tert-butyldisilyl nucleoside compound and synthetic method thereof

Country Status (1)

Country Link
CN (1) CN111944000A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102675389A (en) * 2011-03-08 2012-09-19 大连大学 5-iodine-4-sulfur-2'-deoxyuridine, and derivatives and synthetic method thereof
CN102718822A (en) * 2012-05-18 2012-10-10 大连大学 Synthetic method of 4-sulfur thymidine and analogues of 4-sulfur thymidine under microwave irradiation
CN110105416A (en) * 2019-06-17 2019-08-09 大连大学 A kind of 4-S-5-Br-2 ', 3 ', 5 '-O- triacetyl uridine synthetic methods
CN110204584A (en) * 2019-06-17 2019-09-06 大连大学 A kind of 4-S-2 ', 3 ', 5 '-O- triacetyl uridine synthetic methods

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102675389A (en) * 2011-03-08 2012-09-19 大连大学 5-iodine-4-sulfur-2'-deoxyuridine, and derivatives and synthetic method thereof
CN102718822A (en) * 2012-05-18 2012-10-10 大连大学 Synthetic method of 4-sulfur thymidine and analogues of 4-sulfur thymidine under microwave irradiation
CN110105416A (en) * 2019-06-17 2019-08-09 大连大学 A kind of 4-S-5-Br-2 ', 3 ', 5 '-O- triacetyl uridine synthetic methods
CN110204584A (en) * 2019-06-17 2019-09-06 大连大学 A kind of 4-S-2 ', 3 ', 5 '-O- triacetyl uridine synthetic methods

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
PETER C. TLATELPA等: "Stability of pyrimidine N-glycosydic bonds in the presence of Lawesson’s reagents: revisit of 2-thiolation of pyrimidine nucleosides", 《TETRAHEDRON LETTERS》 *
WING L. SUNG: "Chemical Conversion of Uridine into 4-Thiouridine via the 4-(1,2,4-Triazol-l -yl)pyrimidin-2(1 H)-one Intermediate", 《J. CHEM. SOC., CHEM. COMMUN.》 *
YAO-ZHONG XU等: "Simple Synthesis of 4-Thiothymidine, 4-Thiouridine and 6-Thio-2’-deoxyguanosine", 《TETRAHEDRON LETTERS》 *
银鸿雁 等: "荧光素标记5-溴-4-硫-2′-脱氧尿苷合成及荧光光谱研究", 《分子科学学报》 *

Similar Documents

Publication Publication Date Title
JP6673373B2 (en) Pseudo-solid phase protecting groups and nucleotides
JP7280248B2 (en) Amidite compound and method for producing polynucleotide using said compound
CN102282155B (en) The synthetic method of the nucleic acid of phosphorus atoms modification
EP0241363B1 (en) Nucleoside derivatives and their use in the synthesis of oligonucleotides
ES2830784T3 (en) Process for the preparation of gemcitabine- [phenyl (benzoxy-L-alanyl)] phosphate
CA2192950A1 (en) Novel method of preparation of known and novel 2'-modified nucleosides by intramolecular nucleophilic displacement
MXPA92005623A (en) Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use.
CN107207555A (en) Precipitation promoter and use its intermediate processing
WO2020017085A1 (en) Alkoxyphenyl derivative, nucleoside protector, nucleotide protector, method for producing oligonucleotide, and method for removing substituent
EP3660021B1 (en) Photoresponsive nucleotide analog capable of photocrosslinking in visible light region
CN108424433A (en) A kind of α nucleosides synthetic method
AU711814B2 (en) Nucleoside derivatives with photolabile protective groups
EP0214708B1 (en) Griseolic acid derivatives, their preparation and their use
DE69824843T2 (en) PROCESS FOR PRODUCING MODIFIED P-CHIRAL NUCLEOTIDE ANALOGUE
EP0611075B1 (en) Modified oligodeoxyribonucleotides, their preparation and their therapeutic use
CN111944000A (en) 5-substituted-2, 4-dithio-2 ', 3' -O-di-tert-butyldisilyl nucleoside compound and synthetic method thereof
CN115181147A (en) Preparation method of C4 '-trifluoromethylthio modified nucleoside and C4' -trifluoromethylthio modified nucleic acid
CN111423483A (en) Cyclic dinucleotide prodrug molecule and preparation method and application thereof
Lee et al. Partition property of 5-nitrothiopyrimidine nucleoside
CN112175032B (en) Rapid synthesis method of 5-substituted-4-sulfur-2 ',3' -O-di-tert-butyldisilyl deoxynucleoside compound
CN106336443B (en) The synthetic method of a kind of nucleoside compound
JP6429264B2 (en) Boranophosphate compounds and nucleic acid oligomers
Goj et al. Synthesis of Genistein 2, 3-anhydroglycoconjugates—Potential antiproliferative agents
US9920319B2 (en) 2′/3′/5′-(R/S)-serinyl functionalized oligonucleotides
US20030149284A1 (en) Method of synthesizing a paclitaxel derivative

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20201117